Werewolf Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $21,000 | $0 | $0 | $0 |
Gross Profit | 18,548 | -398 | -400 | |
EBITDA | 10,989 | -11,766 | -6,612 | -14,627 |
EBIT | 8,537 | -12,164 | -7,012 | -15,029 |
Net Income | 3,670 | -13,532 | -8,381 | -16,370 |
Net Change In Cash | 21,000 | 0 | 0 | 0 |
Free Cash Flow | 6,629 | -10,597 | -11,024 | -15,156 |
Cash | 21,987 | 46,450 | 57,050 | 65,711 |
Basic Shares | 48,597 | 49,388 | 46,810 | 45,804 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,885 | $19,943 | $16,401 |
Gross Profit | -1,634 | 71 | 18,179 | 16,401 |
EBITDA | -53,914 | -64,045 | -32,465 | -54,952 |
EBIT | -55,548 | -65,859 | -34,229 | -56,056 |
Net Income | -60,822 | -70,515 | -37,368 | -51,564 |
Net Change In Cash | 0 | 1,885 | 19,943 | 16,401 |
Cost of Revenue | -28,301 | |||
Free Cash Flow | -60,292 | -56,442 | -33,381 | -44,207 |
Cash | 57,951 | 110,995 | 134,343 | 129,315 |
Basic Shares | 46,810 | 43,859 | 35,646 | 28,864 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.08 |
2026-03-31 | -$0.28 |
2025-12-31 | -$0.17 |
2025-09-30 | -$0.36 |